Literature DB >> 19639513

Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab refractory patients.

Michal Sieniawski, Shilpa Bhartia, Jennifer Wilkinson, Stephen John Proctor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639513     DOI: 10.1080/10428190903144667

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  2 in total

1.  Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial".

Authors:  Theodoros P Vassilakopoulos; John Apostolidis; Maria K Angelopoulou
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

2.  Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement.

Authors:  Byung Woog Kang; Joon Ho Moon; Yee Soo Chae; Soo Jung Lee; Jong Gwang Kim; Yeo-Kyeoung Kim; Je-Jung Lee; Deok-Hwan Yang; Hyeoung-Joon Kim; Jin Young Kim; Young Rok Do; Keon Uk Park; Hong Suk Song; Ki Young Kwon; Min Kyung Kim; Kyung Hee Lee; Myung Soo Hyun; Hun Mo Ryoo; Sung Hwa Bae; Hwak Kim; Sang Kyun Sohn
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.